Hong Kong - Novotech, a leading biotech specialist CRO in the Asia-Pacific region, with more than 2,000 staff globally, has joined the GoGive1 campaign, where for every fully vaccinated team member a vaccine is donated to a person in a lower income country.
A recent company-wide survey showed 95% of team members have had at least 1 dose or plan to be vaccinated.
Novotech joined the GoGive1 campaign, backed by the WHO Foundation and GAVI, as part of the company’s COVID-19 safe workplace initiative.
The Novotech workplace policy requires team members who work in the office, visit sites or travel to provide evidence that they have been fully vaccinated.
Novotech CEO John Moller said:
“Providing a safe working environment for staff is a priority for all employers around the world, and at Novotech we have an additional duty to protect the healthcare workers and patients at the sites we visit.
Our COVID-19 vaccination policy supports our objective of reaching full vaccination across the company.
Our approach considers local vaccine availability and rollout, and we are funding vaccinations for Team Members where there is limited government support or to accelerate the vaccination process.
As part of this program, Novotech is donating one vaccine for every fully vaccinated team member, to a lower income country via the WHO and GAVI GoGive1 initiative.”
Novotech’s Chief People Officer, Angela Edwardson said:
“Since vaccines have become available, we have strongly encouraged our Team Members to get vaccinated.
We have overwhelming support for our company policy that employees should be fully vaccinated on their return to the office. Meanwhile our flexible work options will also allow unvaccinated employees to work remotely as we transition.
We look forward to welcoming teams back to the office as restrictions ease across our regions.”
Our key initiatives
- Novotech is funding vaccination for team members in countries that have limited government support, or to accelerate the vaccination process.
- Team members who work in the office, visit sites or travel will need to provide evidence that they have been fully vaccinated or have received a negative test result.
- Policy implementation will be phased and dependent on vaccine rollout and availability in each location
- Novotech’s flexible working options facilitate Team Members to receive their vaccinations during normal working hours
Novotech’s vaccine donation and matching programs
Go Give 1 incentive program
For every fully vaccinated team member, Novotech will donate 1 Vaccine via the GoGive1 program. GoGive1 was created by the WHO Foundation and GAVI (https://www.gavi.org/gavi-covax-amc). Novotech has the potential to contribute over 2,000 vaccinations via this program
Donation Matching Program
In May 2021, Novotech ran a donation matching initiative, matching all employee donations to Care.org, to provide urgent funding to India during the peak of their COVID-19 outbreak.
Media contact
Toyna Chin
노보텍(Novotech) 소개
1997년 설립된 노보텍은 글로벌 full-service CRO이며 바이오텍과 제약회사와의 파트너십을 통해 임상의 모든 단계에서 혁신적이면서도 새로운 치료제 개발을 가속하는 데 주력하고 있습니다.
노보텍은 CRO 업계에서의 선도적인 역할을 인정받아 다수의 권위 있는 상을 수상하였습니다. 2024년에는 Frost & Sullivan의 Global Biotech CRO Award, Clinical Trials Arena Award for Excellence in Business Expansion, Marketing, and Innovation, Employer of Choice, 미국 Great Place to Work 인증, Brandon Hall Gold Award를 수상하였으며, 2023년에는 CRO Leadership Award와 Asia Pacific Cell & Gene Therapy Clinical Trials Excellence를 수상하였습니다. 또한, 2006년부터 Asia-Pacific Contract Research Organization Company of the Year Award를 수상하며 업계에서의 입지를 공고히 하고 있습니다.
노보텍은 연구소, 임상 1상 시험 기관, 약물 개발 컨설팅 서비스, 규제 전문성 등 종합적인 서비스를 제공하며, 1상에서 4상까지의 임상시험과 생물학적 동등성 연구를 포함해 5000건 이상의 임상 프로젝트에 참여한 경험이 있습니다. 노보텍은 전 세계 지역에 걸쳐 34개 지사와 3000명 이상의 직원을 두고 있으며 신뢰할 수 있는 완전한 형태의 전략 파트너입니다.
더 자세한 정보나 임상시험 관련 상담을 원하신다면, 노보텍 공식 웹사이트를 (www.Novotech-CRO.com) 방문하시기 바랍니다.